The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AADI BIOSCIENCES INC | COM | 00032Q104 | 26,132 | 1,849,402 | SH | SOLE | 1,849,402 | 0 | 0 | ||
| ACLARIS THERAPEU | COM | 00461U105 | 2,532 | 160,835 | SH | SOLE | 160,835 | 0 | 0 | ||
| ALLAKOS INC | COM | 01671P100 | 1,178 | 192,500 | SH | SOLE | 192,500 | 0 | 0 | ||
| ALTIMMUNE INC | COM NEW | 02155H200 | 1,596 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
| AMICUS THERAPEUTICS INC | COM | 03152W109 | 3,028 | 290,000 | SH | SOLE | 290,000 | 0 | 0 | ||
| APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 37,838 | 554,000 | SH | SOLE | 554,000 | 0 | 0 | ||
| ARROWHEAD PHARMACEUTICALS INC | COM | 04280A100 | 2,892 | 87,500 | SH | SOLE | 87,500 | 0 | 0 | ||
| BCLS ACQUISITION CORP- CL A | COM CL A | G0904B105 | 8,448 | 843,122 | SH | SOLE | 843,122 | 0 | 0 | ||
| BELLUS HEALTH INC | COM NEW | 07987C204 | 15,191 | 1,438,500 | SH | SOLE | 1,438,500 | 0 | 0 | ||
| BIOATLA INC | COM | 09077B104 | 4,004 | 520,000 | SH | SOLE | 520,000 | 0 | 0 | ||
| BIOMEA FUSION INC | COM | 09077A106 | 10 | 1,000 | SH | SOLE | 1,000 | 0 | 0 | ||
| CELLDEX THERAPEUTICS INC | COM NEW | 15117B202 | 7,511 | 267,195 | SH | SOLE | 267,195 | 0 | 0 | ||
| DICE THERAPEUTICS INC | COM | 23345J104 | 136 | 6,700 | SH | SOLE | 6,700 | 0 | 0 | ||
| ESPERION THERAPEUTIC | COM | 29664W105 | 201 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
| EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 2,400 | 303,396 | SH | SOLE | 303,396 | 0 | 0 | ||
| FULCRUM THERAPEUTICS INC | COM | 359616109 | 1,780 | 220,000 | SH | SOLE | 220,000 | 0 | 0 | ||
| GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | 2,827 | 243,250 | SH | SOLE | 243,250 | 0 | 0 | ||
| GOSSAMER BIO INC | COM | 38341P102 | 3,408 | 284,500 | SH | SOLE | 284,500 | 0 | 0 | ||
| HORIZON THERAPEUTICS PLC | SHS | G46188101 | 248 | 4,000 | SH | SOLE | 4,000 | 0 | 0 | ||
| IDEAYA BIOSCIENCES INC | COM | 45166A102 | 149 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
| IMMUNOGEN INC | COM | 45253H101 | 669 | 140,000 | SH | SOLE | 140,000 | 0 | 0 | ||
| IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 1,472 | 153,639 | SH | SOLE | 153,639 | 0 | 0 | ||
| IVERIC BIO INC | COM | 46583P102 | 10,111 | 563,607 | SH | SOLE | 563,607 | 0 | 0 | ||
| JIYA ACQUISITION CORP -CL A | COM CL A | 47760M102 | 5,608 | 562,500 | SH | SOLE | 562,500 | 0 | 0 | ||
| KINNATE BIOPHARMA INC | COM | 49705R105 | 60 | 5,000 | SH | SOLE | 5,000 | 0 | 0 | ||
| KURA ONCOLOGY INC. COMMON STOCK | COM | 50127T109 | 7,329 | 536,500 | SH | SOLE | 536,500 | 0 | 0 | ||
| MERUS BV | COM | N5749R100 | 1,182 | 59,000 | SH | SOLE | 59,000 | 0 | 0 | ||
| MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | 5,487 | 597,026 | SH | SOLE | 597,026 | 0 | 0 | ||
| MIRATI THERAPEUTICS | COM | 60468T105 | 7,319 | 104,800 | SH | SOLE | 104,800 | 0 | 0 | ||
| NGM BIOPHARMACEUTICALS INC | COM | 62921N105 | 98 | 7,500 | SH | SOLE | 7,500 | 0 | 0 | ||
| NUVATION BIO INC | *W EXP 07/07/2027 | 67080N119 | 15 | 90,832 | SH | SOLE | 90,832 | 0 | 0 | ||
| PMV PHARMACEUTICALS INC | COM | 69353Y103 | 1,839 | 154,500 | SH | SOLE | 154,500 | 0 | 0 | ||
| PYXIS ONCOLOGY INC | COMMON STOCK | 747324101 | 1,318 | 669,158 | SH | SOLE | 669,158 | 0 | 0 | ||
| RELMADA THERAPEUTICS INC | COM | 75955J402 | 13,535 | 365,618 | SH | SOLE | 365,618 | 0 | 0 | ||
| RELMADA THERAPEUTICS INC | PUT | 75955J402 | 7,404 | 200,000 | SH | Put | SOLE | 200,000 | 0 | 0 | |
| REZOLUTE INC | COM NEW | 76200L309 | 1,148 | 419,145 | SH | SOLE | 419,145 | 0 | 0 | ||
| SAREPTA TEHRAPEUTICS INC | COM | 803607100 | 4,587 | 41,500 | SH | SOLE | 41,500 | 0 | 0 | ||
| SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 143 | 5,000 | SH | SOLE | 5,000 | 0 | 0 | ||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 7,800 | 324,614 | SH | SOLE | 324,614 | 0 | 0 | ||
| TERNS PHARMACEUTICALS INC | COM | 880881107 | 2,066 | 350,702 | SH | SOLE | 350,702 | 0 | 0 | ||
| TREVI THERAPEUTICS INC | COM | 89532M101 | 56 | 36,302 | SH | SOLE | 36,302 | 0 | 0 | ||
| UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 5,758 | 27,500 | SH | SOLE | 27,500 | 0 | 0 | ||
| VAXCYTE INC | COM | 92243G108 | 2,040 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | ||
| VENTYX BIOSCIENCES INC | COM | 92332V107 | 6,284 | 180,000 | SH | SOLE | 180,000 | 0 | 0 | ||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 7,440 | 362,735 | SH | SOLE | 362,735 | 0 | 0 | ||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 9,837 | 272,500 | SH | SOLE | 272,500 | 0 | 0 | ||
| ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | 108 | 5,000 | SH | SOLE | 5,000 | 0 | 0 | ||